Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

BUY
$9.01 - $12.01 $2,090 - $2,786
232 Added 87.22%
498 $4,000
Q4 2020

Feb 04, 2021

SELL
$9.23 - $18.18 $4,947 - $9,744
-536 Reduced 66.83%
266 $4,000
Q3 2020

Nov 02, 2020

BUY
$9.38 - $12.48 $1,388 - $1,847
148 Added 22.63%
802 $8,000
Q4 2019

Jan 31, 2020

SELL
$8.03 - $11.7 $578 - $842
-72 Reduced 9.92%
654 $5,000
Q2 2019

Jul 24, 2019

BUY
$8.75 - $13.03 $673 - $1,003
77 Added 11.86%
726 $8,000
Q1 2019

Apr 26, 2019

BUY
$7.72 - $12.81 $1,405 - $2,331
182 Added 38.97%
649 $6,000
Q1 2018

May 02, 2018

BUY
$16.7 - $26.35 $7,798 - $12,305
467 New
467 $9,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $183M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.